Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer.
JCO precision oncology(2023)
摘要
Trastuzumab deruxtecan treatment of 3 patients with HER2/neu-expressing serous endometrial cancer resulted in objective response
更多查看译文
关键词
cancer,her2/neu-expressing,fam-trastuzumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要